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Background: Recovery of walking post-stroke is highly variable. Accurately measuring
and documenting functional brain activation characteristics during walking can help guide
rehabilitation. Previous work in this area has been limited to investigations of frontal
brain regions and have not utilized recent technological and analytical advances for
more accurate measurements. There were three aims for this study: to characterize
the hemodynamic profile during walking post-stroke, to investigate regional changes
in brain activation during different phases of walking, and to related brain changes to
clinical measures.
Methods: Functional near-infrared spectroscopy (fNIRS) along the pre-frontal, premotor,
sensorimotor, and posterior parietal cortices was used on twenty individuals greater than
six months post-stroke. Individual fNIRS optodes were digitized and used to estimate
channel locations on each participant and short separation channels were used to control
for extracerebral hemodynamic changes. Participants walked at their comfortable pace
several times along a hallway while brain activation was recorded. Exploratory cluster
analysis was conducted to determine if there was a link between brain activation and
clinical measures.
Results: Sustained activation was observed in the pre-frontal cortex with the
ipsilesional hemisphere showing greater activation compared to the contralesional side.
Sensorimotor cortex was active during the early, acceleration stage of walking only.
Posterior parietal cortex showed changes in activation during the later, steady-state
stage of walking. Faster gait speeds also related to increased activation in contralesional
sensorimotor and posterior parietal cortices. Exploratory analysis clustered participants
into two distinct groups based on their brain activation profiles and generally showed
that individuals with greater activation tended to have better physical outcomes.
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Conclusions: These findings can guide future research for obtaining adequate power
and determining factors that can be used as effect modifiers to reduce inter-subject
variability. Overall, this is the first study to report specific oxygenated and deoxygenated
hemoglobin changes in frontal to parietal regions during walking in the stroke population.
Our results shed light on the importance of measuring brain activation across the cortex
and show the importance of pre-frontal, sensorimotor, and posterior parietal cortices in
walking after a stroke.
Keywords: functional near-infrared spectroscopy (fNIRS), gait, stroke, pre-frontal cortex (PFC), premotor cortex
(PMC), sensorimotor cortex (SMC), posterior parietal cortex (PPC)

INTRODUCTION

the pre-frontal cortex (PFC) due to its accessibility, with fewer
studies measuring premotor cortex (PMC), and sensorimotor
cortex (SMC) (10). One fNIRS study has specifically shown
a sustained elevation in HbO in PFC and supplementary
motor area during the entire walking period (11). Overall,
the magnitude of activation, especially when the activation is
symmetrical, is commonly related to faster and more symmetrical
walking post-stroke (12–14). Individuals with more severe
hemiparesis also showed greater PFC and PMC activation
compared to those with less severe strokes (13). Poor walking
performance (i.e., increased stride-time variability) in healthy
adults also show increased SMC activation in addition to elevated
PMC activity (15). It is currently unclear whether increased
activation in all cortical regions is related to stroke severity or if
it is beneficial to walking performance after stroke. Additionally,
although previous work in both felines (16) and humans (17, 18)
have shown that activation in the posterior parietal cortex (PPC)
are important during walking, to date, no fNIRS studies have
assessed activation in these areas during walking post-stroke.
Thus, a more thorough assessment of activation across the cortex
and its relation to clinical measures is needed.
Our systematic review showed that the majority of fNIRS
studies in stroke have methodological limitations that impact
interpretation of the results (10). Notably, none of the
studies utilize methods to control for extracerebral changes
in hemoglobin, which can significant confound fNIRS signals
(7, 19). Short-separation channels, which are optode pairs
separated by < 1.5 cm, can be used to measure and then
remove extracerebral hemoglobin changes and motion artifacts.
Additionally, since inter-subject deviations in optode placement
can result in measurements from functionally different cortical
regions, accurate localization of the optodes is needed. None
of the studies utilize methods to improve accuracy, which
may impact the overall interpretation of regional activation
(20). Thus, using both short-separation channels and individual
localization of optodes in a study could improve methodology to
a point that increases confidence in brain activity results.
The current study was designed to examine activation patterns
across multiple cortical regions and relate activation with stroke
impairment and gait performance. Three aims were addressed
within this study: 1) to describe the hemodynamic response
profile with walking after stroke, 2) to determine if there are
regional brain activation differences between phases of walking

Recovery of walking is a primary rehabilitation goal post-stroke
(1), but this recovery tends to be quite variable (2) and the
proportion of individuals who regain full community walking
function is limited (3). Stroke is a direct injury of the brain,
but the functional characteristics of the brain are rarely assessed
during the rehabilitation process. With the variability in walking
recovery, measuring and documenting brain characteristics can
help guide the prescription of rehabilitation treatments (4).
Functional near-infrared spectroscopy (fNIRS) is an
increasingly popular tool for measuring brain activation.
Its portability, relatively low sensitivity to motion artifacts, and
low cost has made it an appealing tool for measuring the brain
during walking (5). fNIRS uses paired optodes of near-infrared
light emitters and detectors separated by 3–4 cm. This separation
distance allows for recording depth of 1.5–2 cm (i.e., reaching the
cortical layer of the cerebral cortex) and a relatively high spatial
resolution compared to electroencephalography (EEG). These
optodes can be placed along a multitude of areas on the scalp
to estimate the changes in concentration of both oxygenated
(HbO) and deoxygenated (HbR) hemoglobin in the area. Using
the neurovascular coupling theory, these changes in hemoglobin
concentrations—increased HbO and decreased HbR—indicate
increases in cortical brain activation (6, 7).
In healthy adults, the onset of walking from standing
typically shows an immediate decrease in HbO (indicating
oxygen consumption) followed by an increase (indicating oxygen
replenishment/increase oxygen to meet the neuronal demands)
that peaks between 5-10s after walking onset. As walking
continues, this initial increase in HbO declines, and at times,
reaches baseline or below baseline standing levels even before
the walking has ceased (8). The response of HbR is typically
opposite and the change is comparatively smaller in amplitude.
Investigation of the magnitude of activation across the different
walking stages (e.g., acceleration or steady-state walking) is
important for assessing the relative cortical demand at the
different walking stages.
Previous work suggests different hemodynamic response
profiles in the stroke population (9). The hemodynamic profiles
in the stroke population, however, is limited and a more detailed
description of the profiles during walking post-stroke is needed.
In stroke, brain activity to date has been primarily measured over
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Measures

and 3) to determine if changes in brain activity relate to
impairment or walking performance.
We hypothesize that: 1) initial oxyhemoglobin characteristics
will decrease at the onset of walking then elevate and remain
elevated throughout the entire walking period, 2) cortical
regions along the PFC, PMC, SMC, and PPC will increase
activation during walking compared to standing, and the
specific intensity of activation will be dependent on the
phase of walking and the functional role of each region,
and 3) a greater magnitude of activation, especially along the
ipsilesional hemisphere, will relate to less impairment and better
gait performance.

Functional Brain Activation
Functional brain activity was measured using fNIRS. Each
participant’s head circumference was measured to fit the headcap
(EASYCAP GmbH, Germany) that was populated with fNIRS
optodes. The Cz position [10/20 International, (23)] was
measured by marking the intersection between nasion-inion and
periauricular points. The cap was then placed on the participant’s
head with reference to Cz and visually inspected for alignment
along the midsagittal plane.
A wireless and portable fNIRS device (NIRSport2, NIRx
Medical Technology, Germany) was used. This device consists
of 16 LED emitters and 23 silicon photodetectors. Emitters
released near-infrared light at 760 and 850 nm which enabled
measurement of both HbO and HbR. The probe configuration
for this experiment arranged the emitter and detector pairs
to result in 48 long separation channels (approximately 30–
35 mm apart) and 8 short separation channels (8 mm apart)
(Figure 1A). Two different distances were chosen to control
for extracerebral contamination (24). The optodes are wired to
the fNIRS collection device that was worn as a backpack by
the participants. The headcap weighed <1 lb and the backpack
device weighed 4 lbs (Figure 1B). fNIRS data were obtained
using the software Aurora 1.4 (NIRx Medical Technologies,
Berlin, Germany). For each data collection session, calibration
of the fNIRS signal was completed to assess the signal quality.
Channels were classified as “Excellent,” “Acceptable,” “Critical,”
or “Lost.” Classifications were documented for comparison with
pre-processing methods. Data were then continuously sampled
at 4.36 Hz.

METHODS
Participants
Recruitment
Participants were recruited through purposive sampling via
posters at local rehabilitation centers, private clinics, and
online platforms. Previous participants who had agreed to be
contacted for future studies were also informed about the current
study. Study details were approved by the university clinical
research ethics board and all participants provided written and
informed consent.

Screening
Interested individuals were first screened for eligibility via
telephone. Inclusion criteria were as follows: age greater or equal
to 18 years old; telephone-Mini-Mental Status Exam (MMSE)
score of <21/26 (21) indicating mild cognitive impairment at
most; single known stroke incident <6 months previous (chronic
stroke); one-sided hemiparesis; able to walk independently
(gait aids allowed) for continuous 1-min bouts; and able
to understand and follow directions in English. Exclusion
criteria were orthopedic injury impairing current walking and
neurological injury other than stroke.

Probabilistic Localization
Several approaches were taken to improve the accuracy of
localizing functional brain activation. The spatial location of the
optodes on each participant’s head was digitally recorded using a
3D digitizer (Polhemus Patriot, USA) and the software PHOEBE
(25). To further control for the location of digitization within
the optode holder (7 mm diameter), a custom interface between
the optode holder and the digitizing stylus was 3D printed to
consistently place the stylus at the center of the optode holder.

Sample Size Calculation
With data from previous work using fNIRS to examine prefrontal cortex brain activation during walking in the stroke
population (22), a sample size of 21 participants was estimated
to identify a difference between standing and normal-paced
walking (power 80%, alpha = 0.05). No data were available to
calculate sample size estimates based on other brain regions
during walking in the stroke population.

Stroke Impairment
The lower extremity portion of the Fugl-Meyer assessment
(FMLE) (26) was used to evaluate motor impairment after stroke
and was completed by a trained physiotherapist. This assessment
has excellent inter- (27) and intra-rater (28) reliability, and is
a recommended outcome measure for individuals living after
stroke (29).

Demographic Data
Task Performance

Age, sex, gait aid used, and global cognition (using the Montreal
Cognitive Assessment Tool) were collected. Stroke characteristics
were obtained through medical charts when available. When
charts were not available, details on time post-stroke, and stroke
type (ischemic/hemorrhagic) were collected through verbal
reports by the participants. Lesion location was determined
through structural MRI obtained through medical records or
collected for this study when eligible.

Frontiers in Neurology | www.frontiersin.org

Performance was measured using two outcomes: gait speed and
stride-time variability. Gait speed was calculated for every trial by
determining the distance walked during the 30 sec trials and then
calculating speed in meters per second. Stride-time variability
was measured using foot pressure switches (Noraxon, USA) on
the paretic leg. Specifically, four separate pressure sensors were
secured to the sole of the shoe: at the heel, first metatarsal head,
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Task Procedure
Participants completed the walking trials along a 50-meter
hallway. They were first provided with 1–2 familiarization trials
of the walking condition to become accustomed to walking
with the fNIRS backpack. Each trial started with the participant
standing at one end of the hallway. The starting end was
randomly determined by the researcher. After a minimum 30s
quiet stance, a verbal “go” from the researcher indicated the start
of the walking trial and a verbal “stop” indicated the end of
the trial. All participants were given instructions to keep their
head position consistent, avoid talking throughout the walking
trials, and to walk at their normal, comfortable pace. Each
walking trial was 30 s long and was performed 4–5 times. For
all trials, a manual wheelchair and a spotter were positioned
behind the participant for safety. At the end of each walking
trial, participants stood for 5 s. To minimize fatigue associated
with time spent on their feet and extra steps needed to reach the
starting point of the next trial, participants were asked to sit in
the wheelchair after each trial, and then pushed to the end of
the hallway to start the next trial. All trials had at least 30 s of
quiet standing immediately prior to the start of the trial—this
allowed for the fNIRS signals to return to baseline, and a portion
of this period was used for baseline comparisons. The PychoPy3.0
program was used for triggering and timing the trials (30).

Data Processing
Functional Brain Activation
Preprocessing of fNIRS data was completed using an open
source software, HomER2 (31). All HomER2 functions and
corresponding parameters are indicated within square brackets.
Noisy channels were first removed [enPruneChannels: SNRtresh
= 6.67, dRange = 5e−4 to 1e+00, SDrange:0–45] and compared
with the calibration from the Aurora software. Data were
then converted into optical density [hmrIntensity2OD]. Motion
artifacts were then identified by using 0.5s time windows to
determine if the signal exceeded either 20 standard deviations
above the mean signal for each channel or showed a change >100
times in amplitude [hmrMotionArtifactByChannel: tMotion =
0.5, tMask = 1.0, STDEVthresh = 20.0, AMPthresh = 5.00]. The
number of removed channels for each participant can be found
in Supplementary Material (Supplementary Table S2). Motion
correction was then applied using a wavelet transformation
with a 1.5 interquartile range [hmrMotionCorrectWavelet: iqr
= 1.5] (18, 32–34). A lowpass filter of 0.15 Hz was then applied
to the data [hmrBandpassFilt: lpf = 0.15] and converted to
hemoglobin concentration using the modified Beer-Lambert
equation [hmrOD2Conc: ppf = 6.0] (35, 36). The hemodynamic
response was estimated using a general linear model with an
ordinary least squares approach (37, 38) and a 0.5 s width and
0.5 s step consecutive gaussian basis function (39). Superficial
contributions to the signal were also removed by regressing
out the data from the short separation channel that has the
highest correlation to each channel (19, 37, 39–41). Any drift
within the signal was corrected using a 3rd order polynomial
correction (37) [hmrDeconvHRF_DriftSS: trange = −20.0 35.0,
glmSolveMethod = 1, idxBasis = 1, paramsBasis= 0.5 0.5,

FIGURE 1 | (A). Schematic of optode configuration and (B). Example of a
participant wearing the fNIRS device.

fifth metatarsal head, and first distal phalanx. The transmitter was
secured onto the lower leg of the participant and the signal was
sent to a receiver attached to the data collection laptop. Data were
collected at 100 Hz.

Frontiers in Neurology | www.frontiersin.org

4

July 2022 | Volume 13 | Article 904722

Lim et al.

fNIRS During Normal-Paced Walking Post-stroke

Interaction effects between fixed variables were included if it
significantly added to the model, as assessed by the likelihood
ratio test. The R package “lme4” was used for the linear mixedeffects models.
As large inter-subject variability has been previously
reported in functional brain activation after stroke (45), further
exploration of this variability was identified using k-means
clustering with two clusters to determine the proportion of
participants with distinctly different activation patterns. K-means
clustering was performed for HbO and HbR separately. Data
from both the Accel and Steady segments, both Hemispheres,
and the four region of interests were used to determine a
participant’s cluster designation. K-means clustering (with
twenty random starts) was computed and the clustering that
occurred most frequently was used to cluster the data.

rhoSD_ssThresh = 15.0, flagSSmethod = 1, driftOrder = 3,
flagMotionCorrect = 0].
Preprocessed data were then exported to a custom Matlab
script for baseline corrections (−15 to 0 s before walking onset),
averaging, and visualization of data. Each channel was visually
inspected for remaining motion artifacts or non-physiological
noise. The group responses were averaged across three Segments:
baseline standing (Stand: −10 to 0 s), Acceleration (Accel: 0–
10 s), and Steady-State (Steady: 10–30 s).

Probabilistic Localization
The spatial location of each participant’s optode position was
imported to AtlasViewer (42) and used to project the channels to
the Colin27 atlas brain. Montreal Neurological Institute (MNI)
coordinates and Automated Anatomical Labeling projections
were provided by AtlasViewer and were then translated into
Brodmann labels using the Allen Human Brain Atlas (43) and
the Yale BioImage Suite Package web application (44). Using this
labeling system, channels were then categorized into regions of
interest: PFC, PMC (which was also combined with SMA), SMC,
and PPC on the ipsilesional and contralesional hemispheres.
Individual channel classifications can be found in Supplementary
Material (Supplementary Table S3). Additionally, individual
MRIs were used to determine location of the stroke lesion. If
stroke lesions were present along the cortex, channels that were
projected to lesion sites were removed.

Aim 3
Pearson’s correlations were assessed for each of the regions of
interest to explore the relationship between brain activation and
impairment or performance. For this aim, Accel and Steady
segments were averaged together for each region of interest
and correlated separately to FMLE, gait speed, and stride-time
variability. Relationships with contralesional and ipsilesional
activations were assessed separately, resulting in eight regions
of interest. For further exploration, demographic and clinical
outcome scores were also reported by clusters.

Stride-Time Variability

All Statistics Were Completed Using R Studio

Data were processed using a custom Matlab script (Matlab
2017b). Each stride was visually inspected and marked to
determine stride-time. The first and last 2 strides of each trial
were removed to account for transient stride-time changes.
Stride-time variability was identified as the standard deviation
around the mean for each trial, which was then averaged across
all trials for each participant.

All relevant assumptions and diagnostics were checked for each
statistical test and appropriate modifications were made and
reported if violations occurred. Given the exploratory objectives,
results were reported using a standard alpha of 0.05 in order not
to miss potential effects. Data are also shown with a Bonferroni
correction for reducing Type 1 error by running multiple models
(p ≤ 0.0125 = 0.05/4 models and regions) and a BenjaminiHochberg false discovery rate of 5% to correct for multiple
Pearson’s correlations.

Statistical Analyses
Aim 1
The group average of the hemodynamic responses was used to
describe the temporal characteristics of the response. Specifically,
for each region of interest, a baseline threshold was determined
by calculating the baseline mean (−10 to 0 s before walking
onset) then two standard deviations above and below this
mean. Time points were identified when the signal deviated
away from and returned to the baseline threshold and at peak
positive/negative responses.

RESULTS
Twenty-two participants were eligible for the study and 20
participants completed the study. Two eligible participants were
not able to attend data collection sessions due to restrictions as
a result of the COVID-19 pandemic. Table 1 shows a summary
of participant demographics. Individual participant data can be
found in Supplementary Materials.

Aim 2

Aim 1: Temporal Hemodynamic Response
Profile

Four separate linear mixed-effects models were used to predict
regional brain activation with walking for each hemoglobin
species (i.e., HbO and HbR). The model included Participants
as random effects and the following fixed effects were then
independently tested for significant contributions to the model:
Segment (Stand, Accel, Steady), Hemisphere (contralesional,
ipsilesional), and Lesion Side (left, right). If an independent
fixed effect significantly contributed to the model for any region
of interest comparison, it was included in the final model.

Frontiers in Neurology | www.frontiersin.org

Group averaged hemodynamic responses are shown in Figure 2.
The average hemodynamic response profile was similar for HbO
across all eight regions of interest. HbO signals increased above
baseline around 3.4 (1.43) sec and peaked around 7.4 (0.30) sec.
For PFC, the increase in HbO remained elevated until 30.2 and
28.9 sec for the contralesional and ipsilesional side, respectively.
HbO levels did not remain elevated for as long in bilateral PMC,
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Aim 3: Relationship Between Brain
Activation and Impairment or Performance

contralesional SMC, or bilateral PPC−14.9 (3.74) sec. Ipsilesional
SMC activation remained elevated for 27 seconds.
Deoxyhemoglobin profiles for bilateral PFC and ipsilesional
SMC showed an initial increase in HbR starting at 0 (0.58)
sec that peaked at 3.3 (0.95) sec. These regions then decreased
HbR concentration starting at 7.3 (1.7) sec. Bilateral PMC,
contralesional SMC, and bilateral PPC decreased starting at 1.9
(1.64) sec. All regions continued to decrease HbR concentrations
until the walking task finished.

For HbO, positive relationships were observed between Gait
Speed and ipsilesional PFC (r2 = 0.21, p = 0.040), contralesional
SMC (r2 = 0.26, p = 0.023) and contralesional PPC (r2 =
0.29, p = 0.017). A negative relationship was also observed
between Stride-Time Variability and ipsilesional PFC (r2 = 0.29,
p = 0.018). These correlations, however, were not significant
after multiple comparison correction (Figure 4). No significant
relationships were observed with lower extremity impairment
(FMLE) or with any outcomes and HbR.
Further exploration of the brain activation clustering
showed some observable trends in various demographic and
clinical outcomes. In general, individuals in the higher HbO
concentration cluster had better physical outcomes (Table 4).
Minimal clinically important differences (MCID) between the
two clusters were found for gait speed [MCID: 0.04–0.2 m/s (46,
47), cluster difference: 0.18 m/s] and Short Physical Performance
Battery [MCID: 0.55 points (47), cluster difference: 1.9 points].
For the HbR clusters, individuals who were in the lower HbR
concentration cluster (i.e., greater decrease in HbR) had overall
better outcomes (Table 5).

Aim 2: Brain Activation During Walking
The best fit linear mixed-model included Participant as random
effects, and Hemisphere and Segment as fixed effects. No
significant effects on the model were found for Lesion side.
The addition of interaction effects did not significantly add to
the model. Overall, the model’s total explanatory power was
moderate (HbO conditional R2 = 0.19–0.28; HbR conditional
R2 = 0.11–0.19) and the part related to the fixed effects alone
(marginal R2 ) ranged from 0.003–0.05 for HbO and 0.02–0.03
for HbR.
The HbO models showed significant increases in
concentration from Stand to Accel (xdiff = 0.153 µmol)
and Steady (xdiff = 0.112 µmol) in PFC and during Accel
only in SMC (xdiff = 0.104 µmol) (Figure 3A). Significant
differences between hemispheres were observed for SMC with
the ipsilesional hemisphere xdiff = 0.066 µmol (Table 2). The
HbR models showed significant decreases in concentration
during Steady for all regions: PFC xdiff = −0.023 µmol; PMC
xdiff = 0.066 µmol; SMC xdiff = −0.046 µmol; PPC xdiff =
−0.0740 µmol compared to Stand (Figure 3B). Significant
differences between hemispheres were only observed for PFC
with the ipsilesional hemisphere showing 0.019 µmol greater
HbO than the contralesional hemisphere (Table 3). K-means
clustering for HbO grouped nine participants as generally
having lower functional brain activity with walking and 11
showing generally higher activation. HbR clusters resulted in
10 participants having distinctly greater HbR concentration
decreases compared to the other 10 participants.

DISCUSSION
This is the first walking study completed in the stroke
population that described the hemodynamic response profiles
across frontal to parietal regions, showed regional activation
differences, and relationships with clinical measures. Our results
partially supported our hypotheses and are in-line with previous
work. Some of these discrepancies may be explained by our
specific participant pool and the large variability in fNIRS data
across participants.

Sustained PFC Activation and Initiation
Through SMC
Based on results from 11, we hypothesized a sustained activation
for all regions during the entire walking task. Contrary to our
hypothesis, we only observed a sustained HbO response in PFC
and significant differences between Stand and both Accel and
Steady segments for this region only. The differences between
the hemodynamic response profiles in the study by 11 and the
current study may be explained by the study population (i.e.,
subacute stroke with ataxia compared to chronic stroke with no
ataxia). During the sub-acute stage of stroke (13) or when walking
with an additional challenge (34), activation in other brain
regions such as the SMC are increased. This increase in motor
cortex activation appears to decrease with gait recovery (13).
Additionally, when walking is aided by a robotic exoskeleton,
thus making walking easier, PMC and SMC activations are
decreased compared to unassisted walking (48). Along these
lines, our results suggest that individuals in the chronic stage of
stroke, and with independent ambulation abilities, still activate
the PFC throughout the walking task whereas other regions, such
as the SMC, are primarily involved during the initiation and early
stages of walking.

TABLE 1 | Summary of participant demographics and performance.
N = 20
Age [mean (SD)]

64 (7.6) years

Sex (Female/Male)

7/13

Chronicity (months)

82 (67.4) months

Lesion Depth (cortical/subcortical/mixed)
Lesion side (Left/Right)
FMLE (34 max)

0/17/3
7/13
27 (4.9)

MoCA (30 max)

26 (2.6)

Gait Aids (none/walking stick(s)/4 point cane/4
wheeled walker)

12/6/1/1

Gait Speed [mean (SD)]
Stride-time variability of paretic leg [mean (SD)]

Frontiers in Neurology | www.frontiersin.org

0.84 (0.345) m/s Range:
0.15–1.39 m/s
0.08 (0.03) sec
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FIGURE 2 | Average Hemodynamic Responses with Normal–paced Walking for each region of interest. Thick lines indicate group mean response and thin lines
indicates 2 standard errors around the mean.

and decreased brain activation. The majority of work using
stride-time variability as a marker of gait automaticity stems
from the healthy older adult population (50, 51). Although
others have also shown increased gait variability as indicators of
poorer gait performance in the stroke population (52, 53), it’s
unclear if it is a marker of decreased automaticity. Further work
is needed to determine measures of automaticity in the stroke
population. Alternatively, greater brain activation, especially
in the executive function, motor planning, and preparation
areas, may be required for walking in a consistent manner. This
increased activation may be a positive compensatory mechanism
for better gait performance post-stroke.

Of note, a significant decrease in HbR, which also indicates
increased neural activation, was observed during steady-state
walking in PFC, PMC, SMC, and PPC. Previous fNIRS studies in
walking have primarily reported findings in HbO concentrations
(10). Although reporting of HbR is recommended (5, 49), few
studies report these findings and further interpretation of these
findings is limited.

Automaticity
General Trend of More Activation With Lower
Stride-Time Variability (More Automatic)
Interestingly, although a significant relationship between
brain activation and stride-time variability (i.e., marker of
automaticity) was only found for HbO in ipsilesional PFC and
PMC, the overall trend and exploratory cluster findings show
some indication toward greater stride-time variability (i.e., less
automatic gait) relating to decreased brain activation (Figure 4).
This contrasts with our hypothesis of increased automaticity

Frontiers in Neurology | www.frontiersin.org

Posterior Parietal Cortex
This is the first study to explore PPC activation using fNIRS
during walking post-stroke. This region is involved in upright
balance (54) and postural control (55, 56). Other imaging
modalities have found increased activation in this area during
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FIGURE 3 | Average (A) HbO and (B) HbR response for each time segment with for each region of interest. Bars indicate average responses for the contralesional
side (white) and ipsilesional side (colored) and error lines indicate standard error. # Indicates a differences from Baseline with alpha at 0.05 *Indicates a significant
difference from Baseline after correction for multiple comparisons.

channels with robotic-assisted walking in healthy adults (18),
highlighting the importance of measuring activation in this
area. Current results showed decreased HbR concentrations

walking post-stroke [electroencephalography: (57–59); positron
emission topography: (17)]. Additionally, work from our
group primarily showed differences in the posterior parietal

Frontiers in Neurology | www.frontiersin.org
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TABLE 2 | Linear mixed-effects models results for HbO: HbO∼Condition+Hemisphere+(1|Participant).
p

ICC

Nsubj

Observations

Marginal R2 / Conditional R2

−0.104026–0.030353

0.282

0.21

20

843

0.053 / 0.251

0.111363–0.195479

<0.001*

0.27

20

705

0.003 / 0.272

0.26

20

465

0.032 / 0.283

0.19

19

507

0.006 / 0.190

ROI

Predictors

Estimates

Confidence interval

PFC

(Intercept)

−0.036837
0.153421

Segment [Prep]

PMC

Segment [Stdy]

0.111775

0.069717–0.153833

<0.001*

Hemisphere [ipsi]

0.036446

0.001732–0.071160

0.040

(Intercept)

0.005330

−0.086767–0.097426

0.910

Segment [Prep]

0.029432

−0.025459–0.084323

0.293

Segment [Stdy]

−0.014336

−0.069227–0.040555

0.608

0.006386

−0.039135–0.051907

0.783

−0.037187

−0.117869–0.043496

0.366

0.103951

0.046891–0.161011

<0.001*

Segment [Stdy]

0.037538

−0.019522–0.094598

0.197

Hemisphere [ipsi]

0.065918

0.017822–0.114015

0.007*

Hemisphere [ipsi]
SMC

(Intercept)
Segment [Prep]

PPC

(Intercept)

−0.020774

−0.113255–0.071707

0.659

Segment [Prep]

0.030634

−0.040401–0.101670

0.397

Segment [Stdy]

−0.033446

−0.104482–0.037590

0.355

0.018087

−0.040443–0.076617

0.544

Hemisphere [ipsi]

Predictors indicate the fixed effects levels within the variables in the model. Reference levels were Stand for Condition and the contralesional hemisphere for Hemisphere. Estimates
indicate the adjusted difference between the reference level and the predictor level. Bolded p–values indicate significant differences using an alpha of 0.05. * Indicates significant
differences with p ≤ 0.0125 (0.05 /4. Bonferroni correction for four models). Estimates and confidence intervals are described in µmol. PFC, pre-frontal cortex; PMC, premotor cortex;
SMC, sensorimotor cortex; PPC, posterior parietal cortex.

TABLE 3 | Linear mixed–effects models results for HbR: HbR∼Condition+Hemisphere+(1|Participant).
ROI

Predictors

Estimates

PFC

(Intercept)

PMC

SMC

p

ICC

Nsubj

Observations

Marginal R2 / Conditional R2

0.15

20

843

0.020 / 0.163

0.09

20

705

0.029 / 0.120

0.09

20

465

0.023 / 0.113

0.17

19

507

0.026 / 0.190

−0.005865

−0.030568–0.018839

0.641

Segment [Prep]

0.009288

−0.008636–0.027212

0.309

Segment [Stdy]

−0.023347

−0.041271−0.005422

0.011*

Hemisphere [ipsi]

0.019295

0.004509–0.034082

0.011*

(Intercept)

0.012104

−0.018544–0.042753

0.438

Segment [Prep]

−0.034157

−0.061640−0.006675

0.015

Segment [Stdy]

−0.066126

−0.093608−0.038643

<0.001*

Hemisphere [ipsi]

−0.012357

−0.035100–0.010386

0.286

(Intercept)

−0.006921

−0.035947–0.022106

0.640

Segment [Prep]

−0.016582

−0.045085–0.011922

0.254

Segment [Stdy]

−0.045554

−0.074057−0.017051

0.002*

0.016181

−0.007689–0.040051

0.183

(Intercept)

−0.009275

−0.055350–0.036800

0.693

Segment [Prep]

−0.041710

−0.078337−0.005084

0.026

Segment [Stdy]

−0.074196

−0.110822−0.037569

<0.001*

Hemisphere [ipsi]

−0.004291

−0.034464–0.025882

0.780

Hemisphere [ipsi]
PPC

Confidence interval

Predictors indicate the fixed effects levels within the variables in the model. Reference levels were Stand for Condition and the contralesional hemisphere for Hemisphere. Estimates
indicate the adjusted difference between the reference level and the predictor level. Bolded p–values indicate significant differences using an alpha of 0.05. * Indicates significant
differences with p ≤ 0.0125 (0.05 /4: Bonferroni correction for four models). Estimates and confidence intervals are described in µmol. PFC, pre-frontal cortex; PMC, premotor cortex;
SMC, sensorimotor cortex; PPC, posterior parietal cortex.

Hemoglobin Response Predictions and Its
Variability

in PPC with walking. No significant changes were observed
for HbO though large inter-subject variations were present.
The involvement of this area during walking post-stroke
remains uncertain and future work with greater sample sizes
or more stringent inclusion criteria may reveal the role of
this area.

Frontiers in Neurology | www.frontiersin.org

Compared to standing, each region of interest showed a different
response during the Accel and Steady segments of walking.
Our best fit model was able to capture the differences between
segments in each region of interest, but the segment and

9

July 2022 | Volume 13 | Article 904722

Lim et al.

fNIRS During Normal-Paced Walking Post-stroke

FIGURE 4 | Relationships between HbO and impairment, performance, and automaticity for each ROI Ipsilesional and Contralesional hemisphere are plotted on a
single graph and indicated by red and gray markers; respectively. Additionally; individuals in Cluster 1 are denoted by a triangle marker and individuals in Cluster 2 are
denoted by circle markers. # Indicates a relationship with alpha at 0.05.

variability or use physical measures as possible effect modifiers
in analysis.

hemisphere effects only explained up to 3% of the variance
within the data (marginal R2 ). This low percentage suggests other
factors that may explain the variance within HbO and HbR.
Our exploratory analysis point to distinct clusters of activation
patterns and show some differences in physical outcomes
between the clusters. This suggests that future work may want
to either include more stringent inclusion criteria to reduce the

Frontiers in Neurology | www.frontiersin.org

Limitations
Previous reviews have acknowledged a limitation in sample
sizes for fNIRS studies, with the majority including <10
or 15 participants (10, 60, 61). While this study had 20
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TABLE 4 | Demographic and clinical outcome averages split between HbO clusters.
Cluster 1 (N = 11)

Cluster 2 (N = 9)

95% Confidence

Cohen’s D

lower [HbO]

higher [HbO]

interval for difference

effect size

MEAN

SD

MEAN

SD

Age

66

6.4

63

9.0

−4.24–10.24

0.39

Time post–stroke (months)

72

62

94.3

74.89

−86.54–41.94

0.33

Years of post–secondary education

5.3

2.88

4.6

3.78

−2.43–3.83

0.21

Number of comorbidities

0.7

1.10

1.1

1.27

−1.51–0.71

0.34

Activity–specific balance confidence

72.3

20.12

64.3

23.90

−12.66–28.66

0.37

Montreal cognitive assessment

26.7

2.97

26.4

2.07

−2.16–2.76

0.12
0.67

Short physical performance battery

9.7

2.41

7.8

3.27

−0.77–4.57

Timed up and go

16.4

13.00

19.9

12.07

−15.39–8.39

0.28

Fugl–meyer lower extremity

27.8

4.83

25.9

4.91

−2.69–6.49

0.39

Normal–pace gait speed

0.91

0.346

0.73

0.333

−0.14–0.50

0.53

Stride time variability

0.07

0.025

0.09

0.036

−0.05–0.01

0.66

TABLE 5 | Demographic and clinical outcome averages split between HbR clusters.
Cluster 1 (N = 10)

Cluster 2 (N = 10)

95% Confidence

Cohen’s D

lower [HbR]

higher [HbR]

interval for difference

effect size

MEAN
Age

SD

MEAN

SD

62

7.2

67

7.7

−12.00–2.00

0.67

Time post–stroke (months)

71.3

76.18

100.4

57.07

−92.34–34.14

0.43

Years of post–secondary education

5.1

2.67

4.6

4.07

−2.73–3.73

0.15

Number of comorbidities

0.8

1.03

1.0

1.41

−1.36–0.96

0.16

Activity–specific balance Confidence

68.2

23.34

68.5

22.35

−21.77–21.17

0.01

27

2.6

26

2.8

−1.54–3.54

0.37
0.00

Montreal cognitive assessment

9

2.7

9

3.3

−2.83–2.83

Timed up and go

Short physical performance battery

18.0

11.82

18.5

14.14

−12.74–11.74

0.04

Fugl–meyer lower extremity

26.9

4.65

26.6

5.39

−4.43–5.03

0.06

Normal–pace gait speed

0.78

0.300

0.88

0.394

−0.43–0.23

0.29

Stride time variability

0.08

0.038

0.07

0.024

−0.02–0.04

0.31

CONCLUSIONS

participants, sample size calculations were estimated from
studies focusing on PFC activation. This calculation was
likely an underestimation of the sample size needed to
observe changes in other cortical areas. Tables 2, 3 provide
the necessary information for sample size calculations in
future studies.
Although all our participants had observable hemiparetic
gait, we acknowledge that they only represent a portion
of stroke survivors. On average, our participants would
be categorized in the community ambulator walking
category (i.e., gait speed > 0.80 m/s) and this may
explain the lack of hemispheric differences we observed.
Our previous work suggests asymmetrical activation was
more commonly observed in studies with an average
walking speed of 0.05 m/s or slower (10). Further work
in slower or more severely affected walkers is needed
to further explore activation asymmetries as a marker of
gait performance.

Frontiers in Neurology | www.frontiersin.org

Recent technologies (e.g., short-separation channels and
probabilistic channel localization) and analysis methods (e.g.,
motion and extracerebral noise corrections) have enabled
more accurate interpretation of fNIRS data. PFC continues to
show consistent increases in activation during walking with
the ipsilesional hemisphere showing even greater activation.
SMC are active during the acceleration stage of walking and
posterior parietal cortices are activated during the steady-state
portion of walking. Our data also suggest that faster gait
speeds related to greater brain activity in the contralesional
motor and sensory regions. Our results shed light on the
variability within the data, even when extraneous noise is
controlled for. Inter-subject variability within functional
brain data has been well reported in other brain imaging
methodologies and exploratory cluster analysis in the current
study revealed distinct activation responses between participants.
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